Literature DB >> 1503688

Changes in neuropsychological performance of AIDS-related complex patients who progress to AIDS.

N Dunbar1, M Perdices, A Grunseit, D A Cooper.   

Abstract

OBJECTIVE: To investigate the changes in neuropsychological performance associated with progression from AIDS-related complex (ARC) to AIDS.
DESIGN: A repeated measures design was used to compare three groups: ARC patients who progressed to AIDS (n = 15), those who did not (n = 19) and seronegative controls (n = 16).
METHODS: The three groups were compared on tests of memory, information processing, motor performance, attention and conceptual flexibility. Clinical and immunological characteristics were recorded. Rates of neuropsychological impairment among the three groups were calculated and compared.
RESULTS: The only significant difference between the groups at baseline was for one measure of motor performance. Repeated measures analysis indicated that there was a differential rate of change for the three subject groups for tasks of motor performance and attention. ARC patients who progressed to AIDS did not differ significantly from the non-progressors, although both groups showed significant deterioration over time compared with seronegative controls. Although there was a tendency for the progressors to have a higher rate of impairment, there were no consistent significant differences between visits.
CONCLUSION: There were no significant changes in performance exclusively associated with progression to AIDS.

Entities:  

Mesh:

Year:  1992        PMID: 1503688     DOI: 10.1097/00002030-199207000-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  3 in total

1.  Better quality of life with neuropsychological improvement on HAART.

Authors:  Thomas D Parsons; Alyssa J Braaten; Colin D Hall; Kevin R Robertson
Journal:  Health Qual Life Outcomes       Date:  2006-02-24       Impact factor: 3.186

2.  Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

Authors:  Lucette A Cysique; Paul Maruff; Bruce J Brew
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

Review 3.  Human immunodeficiency virus type 1 infection of the brain.

Authors:  W J Atwood; J R Berger; R Kaderman; C S Tornatore; E O Major
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.